Showing results (11-20 of 40) with videos related to
Sort By:
Pageof 4
Cell & Developmental Biology|October 14, 2014
Embryonic Expression and Function of the <i>Xenopus</i> Ink4d Cyclin D-Dependent Kinase InhibitorJoanne R Doherty, Lisa M Nilsson, Emin Kuliyev, et al.Gastro Hep Advances|August 12, 2024
Genetics and Therapeutic Responses to Tumor-Infiltrating Lymphocyte Therapy of Pancreatic Cancer Patient-Derived Xenograft ModelsLisa M Nilsson, Caroline Vilhav, Joakim W Karlsson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2011
Therapeutic implications for the induced levels of Chk1 in Myc-expressing cancer cellsAndreas Höglund, Lisa M Nilsson, Somsundar Veppil Muralidharan, et al.Cells|January 8, 2025
Insulin Sensitivity Controls Activity of Pathogenic CD4+ T Cells in Rheumatoid ArthritisMalin C Erlandsson, Eric Malmhäll-Bah, Venkataragavan Chandrasekaran, et al.Cancer Research|September 23, 2003
Hemangiosarcomas, medulloblastomas, and other tumors in Ink4c/p53-null miceFrederique Zindy, Lisa M Nilsson, Luc Nguyen, et al.Cancer Research|March 5, 2016
Cancer Differentiating Agent Hexamethylene Bisacetamide Inhibits BET Bromodomain ProteinsLisa M Nilsson, Lydia C Green, Somsundar Veppil Muralidharan, et al.Nature Communications|September 29, 2017
Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse modelHenrik Jespersen, Mattias F Lindberg, Marco Donia, et al.American Journal of Physiology. Cell Physiology|November 3, 2006
Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferationLisa M Nilsson, Zheng-Wu Sun, Jenny Nilsson, et al.Elife|September 23, 2024
Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastasesJoakim W Karlsson, Vasu R Sah, Roger Olofsson Bagge, et al.Cell Death & Disease|December 15, 2017
BET bromodomain inhibitors synergize with ATR inhibitors in melanomaSomsundar Veppil Muralidharan, Berglind Osk Einarsdottir, Joydeep Bhadury, et al.Pageof 4